Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.

Tytuł:
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
Autorzy:
Ding BTK; Department of Orthopaedic Surgery, Woodlands Health, 2 Yishun Central 2, Tower E, S768024, Singapore, Singapore. .
Lim HF; Department of Orthopaedic Surgery, Khoo Teck Puat Hospital, 90 Yishun Central, S768828, Singapore, Singapore.
Johari F; Nursing Specialty, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, S308433, Singapore, Singapore.
Kunnasegaran R; Department of Orthopaedic Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, S308433, Singapore, Singapore.
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2023 Feb; Vol. 34 (2), pp. 299-307. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London, UK : Springer International, c1990-
MeSH Terms:
Osteoporotic Fractures*/prevention & control
Osteoporotic Fractures*/surgery
Osteoporotic Fractures*/drug therapy
Orthopedic Surgeons*
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/complications
Osteoporosis*/drug therapy
Osteoporosis*/prevention & control
Humans ; Retrospective Studies ; Cohort Studies ; Patient Compliance ; Secondary Prevention
References:
Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV (2007) Residual lifetime risk of fractures in women and men. J Bone Miner Res 22:781–788. (PMID: 10.1359/jbmr.070315)
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795. https://doi.org/10.1001/jama.285.6.785.
Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387–394. (PMID: 10.1001/jama.297.4.387)
Huybrechts KF, Ishak KJ, Caro JJ (2006) Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 38:922–928. (PMID: 10.1016/j.bone.2005.10.022)
Leslie WD, Giangregorio LM, Yogendran M, Azimaee M, Morin S, Metge C, Caetano P, Lix LM (2012) A population-based analysis of the post-fracture care gap 1996–2008: the situation is not improving. Osteoporos Int 23:1623–1629. (PMID: 10.1007/s00198-011-1630-1)
Greenspan SL, Wyman A, Hooven FH et al (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60:455–461. (PMID: 10.1111/j.1532-5415.2011.03854.x)
Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152. (PMID: 10.1007/s00198-013-2348-z)
Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406. (PMID: 10.1007/s00198-012-2090-y)
Chandran M, Mitchell PJ (2021) Tackling osteoporosis and fragility fractures in Singapore. Ann Acad Med Singap 50:291–293. (PMID: 10.47102/annals-acadmedsg.2021119)
Chandran M, Tan MZ, Cheen M, Tan SB, Leong M, Lau TC (2013) Secondary prevention of osteoporotic fractures–an “OPTIMAL” model of care from Singapore. Osteoporos Int 24:2809–2817. (PMID: 10.1007/s00198-013-2368-8)
Axelsson KF, Jacobsson R, Lund D, Lorentzon M (2016) Effectiveness of a minimal resource fracture liaison service. Osteoporos Int 27:3165–3175. (PMID: 10.1007/s00198-016-3643-2)
Soong Y-K, Tsai K-S, Huang H-Y, Yang R-S, Chen J-F, Wu P-H, Huang K-E (2013) Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int 24:511–521. (PMID: 10.1007/s00198-012-1984-z)
Lih A, Nandapalan H, Kim M, Yap C, Lee P, Ganda K, Seibel M (2011) Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int 22:849–858. (PMID: 10.1007/s00198-010-1477-x)
Boudou L, Gerbay B, Chopin F, Ollagnier E, Collet P, Thomas T (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 22:2099–2106. (PMID: 10.1007/s00198-011-1638-6)
Edwards BJ, Bunta AD, Madison LD, De Santis A, Ramsey-Goldman R, Taft L, Wilson C, Moinfar M (2005) An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Joint Comm J Qual Patient Saf 31:267–274.
Dell R, Greene D, Schelkun SR, Williams K (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg Am 90(Suppl 4):188–194. (PMID: 10.2106/JBJS.H.00628)
McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028–1034. (PMID: 10.1007/s00198-003-1507-z)
McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098. (PMID: 10.1007/s00198-011-1534-0)
Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88:25–34.
Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197–1205. (PMID: 10.2106/JBJS.G.00980)
Cooper MS, Palmer AJ, Seibel MJ (2012) Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23:97–107. (PMID: 10.1007/s00198-011-1802-z)
Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22:2067–2082. (PMID: 10.1007/s00198-011-1544-y)
Javaid MK, Kyer C, Mitchell PJ et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool. Osteoporos Int 26:2573–2578. (PMID: 10.1007/s00198-015-3192-0)
Giles M, Van Der Kallen J, Parker V, Cooper K, Gill K, Ross L, McNeill S (2011) A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporos Int 22:2321–2328. (PMID: 10.1007/s00198-010-1466-0)
Kuo I, Ong C, Simmons L, Bliuc D, Eisman J, Center J (2007) Successful direct intervention for osteoporosis in patients with minimal trauma fractures. Osteoporos Int 18:1633–1639. (PMID: 10.1007/s00198-007-0418-9)
Streeten EA, Mohamed A, Gandhi A, Orwig D, Sack P, Sterling R, Pellegrini VD Jr (2006) The inpatient consultation approach to osteoporosis treatment in patients with a fracture: is automatic consultation needed? JBJS 88:1968–1974.
Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clinic Proceedings. Elsevier, pp 334–338.
Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16–35. (PMID: 10.1002/jbmr.2708)
Pal B, Morris J, Muddu B (1998) The management of osteoporosis-related fractures: a survey of orthopaedic surgeons’ practice. Clin Exp Rheumatol 16:61–62.
Treml J, Husk J, Lowe D, Vasilakis N (2011) Falling standards, broken promises: report of the national audit of falls and bone health in older people 2010. Royal College of Physicians, London.
Skelton D, Neil F (2009) NHS greater glasgow and clyde strategy for osteoporosis and falls prevention 2006–2010: an evaluation 2007–2009. HealthQWest and Glasgow Caledonian University, Glasgow.
Health NIf, Excellence C (2017) Bisphosphonates for treating osteoporosis. National Institute for Health and Care Excellence (NICE), London.
Morizio P, Burkhart JI, Ozawa S (2018) Denosumab: a unique perspective on adherence and cost-effectiveness compared with oral bisphosphonates in osteoporosis patients. Ann Pharmacother 52:1031–1041. (PMID: 10.1177/1060028018768808)
Freemantle N, Satram-Hoang S, Tang E-T, Kaur P, Macarios D, Siddhanti S, Borenstein J, Kendler D (2012) Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23:317–326. (PMID: 10.1007/s00198-011-1780-1)
Contributed Indexing:
Keywords: Bisphosphonates; Fracture liaison service; Fragility fracture; Osteoporosis; Secondary fracture prevention
Substance Nomenclature:
0 (Bone Density Conservation Agents)
Entry Date(s):
Date Created: 20221121 Date Completed: 20230123 Latest Revision: 20230123
Update Code:
20230123
DOI:
10.1007/s00198-022-06595-5
PMID:
36409358
Czasopismo naukowe
This study aims to evaluate the efficacy of an Orthopaedic Surgeon Led Osteoporosis Model of Care (OSLO-MoC) in improving care of patients with primary osteoporotic fractures. The OSLO-MOC has shown to be effective in improving osteoporotic medication initiation and compliance and reducing secondary fracture rates in patients.
Purpose: This study aims to evaluate the efficacy of an Orthopaedic Surgeon Led Osteoporosis Model of Care (OSLO-MoC) as compared to a Case Manager Led Osteoporosis Model of Care (CMLO-MoC) in reducing early osteoporotic re-fracture rates and treatment compliance in patients.
Methods: This was a single centre, retrospective, comparative cohort study of all patients screened and treated for secondary osteoporotic fracture prevention from the 2008 to 2018 at an orthopaedic surgical unit. From the 2008 to 2013, patients were recruited under the CMLO-MoC and from 2014 to 2018, under the OSLO-MOC. Logistics regression analysis was used to identify significant predictors such as OSLO-MOC implementation, gender, ethnicity, marital status and education level for patient recruitment, treatment compliance and secondary fracture rates at 12-month follow-up.
Results: Over a 10-year period, 7388 patients were screened of which 2855 patients were eligible for analysis. A total of 1234 patients were recruited under CMLO-MoC and 1621 patients under OSLO-MOC. Implementation of the OSLO-MOC was associated with greater patient recruitment, OR 1.26 (95%CI 1.06-1.49, P = 0.007). Of the 2855 patients recruited, OSLO-MOC implementation, OR 2.61 (95%CI 2.03-3.36, P < 0.001), and a higher level of education, OR 1.428 (95%CI 1.02-1.43, P = 0.037), were associated with improved compliance to medication at 12 months. OSLO-MOC implementation was the only factor associated with reduced risk of secondary fractures at 12 months, OR 0.14 (95%CI 0.03-0.66, P = 0.013).
Conclusion: The OSLO-MOC has shown to be effective in reducing the rate of re-fracture and osteoporotic medication initiation and compliance of patients.
Level of Evidence: IV.
(© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies